5
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Identification of Gene Products Suppressed by Human Immunodeficiency Virus Type 1 Infection or gp120 Exposure of Primary Human Astrocytes by Rapid Subtraction Hybridization

, , , , , & show all
Pages 372-389 | Published online: 10 Jul 2009

References

  • Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rab s on A, Martin MA (1986). Production of acquired im-munodeficiency syndrome-associated retrovirus in hu-man and nonhuman cells transfected with an infectious molecular clone. J Virol 59: 284–291.
  • An SF, Groves M, Giometto B, Beckett AAJ, Scaravilli F (1999). Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction/in situ hybridisation technique. Acta Neu-ropathol 98: 481–487.
  • Andjelkovic AV, Kerkovich D, Shanley J, Pulliam L, Pachter JS (1999). Expression of binding sites for /3 chemokines on human astrocytes. Glia 28: 225–235.
  • Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected in-dividuals: identification by the combination of in situ polymerase chain reaction and i=unohistochemistry. AIDS 10: 573–585.
  • Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002). Control of synaptic strength by glial TNFa. Science 295: 2282–2285.
  • Bencheikh M, Bentsman G, Sarkissian N, Canki M, Volsky DJ (1999). Replication of different clones of human im-munodeficiency virus type 1 in primary fetal human as-trocytes: enhancement of viral gene expression by Nef. JNeuroViro/ 5: 115–124.
  • Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001). CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702–710.
  • Bondy CA, Lee WH (1993). Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann N Y Acad Sci 692: 33–43.
  • Brack-Werner R (1999). Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13: 1–22.
  • Budka H (1991). Neuropathology of human immunodefi-ciency virus infection. Brain Pathol 1: 163–175.
  • Canki M, Thai JNF, Chao W, Ghorpade A, Potash MJ, Volsky DJ (2001). Highly productive infection with pseudo-typed human immunodeficiency virus type 1 (HIV-1) in-dicates no intracellular restrictions to HIV-1 replication in primary human astrocytes. J Virol 75: 7925–7933.
  • Cheng-Mayer C, Rutka JE, Rosenblum ML, McHugh T, Stites DP, Levy JA (1987). Human immunodeficiency virus can productively infect cultured human glial cells. Proc Nati Acad Sci USA 84: 3526–3530.
  • Choe W, Volsky DJ, Potash MJ (2001). Induction of rapid and extensive /3-chemokine synthesis in macrophagesby human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J Virol 75: 10738–10745.
  • Choe W, Volsky DJ, Potash MJ (2002). Activation of NF-KB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1a and tu-mor necrosis factor-a in macrophages. J Virol 76: 5274–5277.
  • Choi DW (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634.
  • Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D (1998). HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391: 397–401.
  • Conant K, Ma M, Nath A, Major EO (1996). Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-KB binding and protein kinase C activity in primary human astrocytes. J Virol 70: 1384–1389.
  • Conant K, Major EO (1998). Astrocytes as mediators of CNS injury in AIDS. In: The Neurology of AIDS. Gendelman HE, Lipton AS, Epstein L, Swindells S (eds). New York: Chapman & Hall.
  • Cook SJ, Rubinfeld B, Albert I, McCormick F (1993). RapV12 antagonizes ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts. EMBO J 12: 3475–3485.
  • Corbeil J, Sheeter D, Genini D, Rought S, Leoni L, Du P, Ferguson M, Masys DR, Welsh JB, Fink JL, Sasik R, Huang D, Drenkow J, Richman DD, Gingeras T (2001). Temporal gene regulation during HIV-1 infec-tion of human CD4+ T cells. Genome Res 11: 1198–1204.
  • Danbolt NC (2001). Glutamate uptake. Prog Neurobiol 65: 1–105.
  • Dewhurst S, Sakai K, Bresser J, Stevenson M, Evinger-Hodges MJ, Volsky DJ (1987). Persistent productive in-fection of human glial cells by human immunodefi-ciency virus (HIV) and by infectious molecular clones of HIV. J Virol 61: 3774–3782.
  • Dong Y, Benveniste EN (2001). Immune function of astro-cytes. Glia 36: 180–190.
  • Dou D, Joseph R (1996a). Structure and organization of the human neuronatin gene. Genomics 33: 292–297.
  • Dou D, Joseph R (1996b). Cloning of human neuronatin gene and its localization to chromosome-20q 11.2-12: the deduced proteins is a novel "proteolipid". Brain Res 723: 8–22.
  • Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J (2001). Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling mod-ule. J Exp Med 194: 255–264.
  • Fermin CD, Garry RF (1992). Membrane alterations linked to early interactions of HIV with the cell surface. Virol-ogy 191: 941–946.
  • Fitter S, Tetaz TJ, Berndt MC, Ashman LK (1995). Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetra-span antigen, PETA-3. Blood 86: 1348–1355.
  • Frost RA, Fuhrer J, Steigbigel R, Mariuz P, Lang CH, Gelato MC (1996). Wasting in the acquired immune de-ficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin En-docrinol 44: 501–514.
  • Geiss GK, Bumgamer RE, An MC, Agy MB, van 't Wout AB, Hammersmark E, Carter VS, Upchurch D, Mullins JI, Katze MG (2000). Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA mi-croarrays. Virology 266: 8–16.
  • Graham FL, Smiley J, Russell WC, Nairn R (1977). Charac-teristics of a human cell line transformed by DNA from human adenovirus type 5.1 Gen Virol 36: 59–74.
  • Gubler U, Hoffman BJ (1983). A simple and very efficient method for generating cDNA libraries. Gene 25: 263–269.
  • Gupta S, Vayuvegula B (1987). Human immunodeficiency virus-associated changes in signal transduction. J Clin Immunol 7: 486–489.
  • Harouse JM, Knusch C, Hartle HT, Laughlin AM, Hoxie AJ, Wigdahl B, Gonzales-Scarano F (1989). CD-independent infection of human neural cells by human immunodefi-ciency virus type 1.1 Virol 63: 2527–2533.
  • He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay RC, Sodroski J, Gabuzda D (1997). CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645–649.
  • Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB (1999a). Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene 18: 3546–3552.
  • Huang F, Adelman J, Jiang H, Goldstein NI, Fisher PB (1999b). Differentiation induction subtraction hy-bridization (DISH): an approach for cloning genes dif-ferentially expressed during growth arrest and termi-nal differentiation in human melanoma cells. Gene 236: 125–131.
  • Lino M, Goto K, Kakegawa W, Okado H, Sudo M, Ishiuchi S, Miwa A, Takayasu Y, Saito I, Tsuzuki K, Ozawa S (2001). Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann Glia. Science 292: 926–929.
  • Jain S, Golde DW, Bailey R, Geffner ME (1998). Insulin-like growth factor-I resistance. Endocr Rev 5: 625–646.
  • Jiang H, Fisher PB (1993). Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol Cell Different 1: 285–299.
  • Jiang H, Kang D-C, Alexandre D, Fisher PB (2000). RaSH, a rapid subtraction hybridization approach for identi-fying and cloning differentially expressed genes. Proc Nail Acad Sci USA 97: 12684–12689.
  • Kang D-C, Jiang H, Wu Q, Pestka S, Fisher PB (2001). Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hy-bridization protocol RaSH. Gene 267: 233–242.
  • Kang D-C, Jiang H, Su Z-Z, Volsky DJ, Fisher PB (2002). RaSH-Rapid subtraction hybridization. In: Analysing gene expression. Lorkowski S, Cullen P (eds). Germany: Wiley-VCH Verlag GmbH, pp 206–214.
  • Kang D-C, LaFrance R, Su Z-Z, Fisher PB (1998). Recip-rocal subtraction differential RNA display (RSDD): an efficient and rapid procedure for isolating differentially expressed gene sequences. Proc Nail Acad Sci USA 95: 13788–13793.
  • Kimpton J, Emerman M (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated /3-galactosidase gene. J Virol 66: 2232–2239.
  • Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L (1984). T-lymphocyte T4 molecule behaves as the receptor for hu-man retrovirus LAV. Nature 312: 767–768.
  • Köller H, Schaal H, Freund M, Garrido SR, von Giesen H-J, Ott M, Rosenbaum C, Arendt G (2001). HIV-1 protein Tat reduces the glutamate-induced intracellular Ca2+ in-crease in cultured cortical astrocytes. Eur Neurosci 14: 1793–1799.
  • Kremerskothen J, Zopf D, Walter P, Cheng JG, Nettermann M, Niewerth U, Maraia RJ, Brosius J (1998). Heterodimer SRP9/14 is an integral part of the neural BC200 RNP in primate brain. Neurosci Lett 245: 123–126.
  • Levy JA (1993). Pathogenesis of human immunodeficiency virus infection. Microbic)] Rev 57: 183–289.
  • Liebhaber SA, Emery JG, Urbanek M, Wang X, Cooke NE (1990). Characterization of a human cDNA encoding a widely expressed and highly conserved cysteine-rich protein with an unusual zinc-finger motif. Nucleic Acids Res 18: 3871–3879.
  • Lipton S, Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. New Engl J Med 233: 934–940.
  • Liitcke H (1995). Review: signal recognition particle (SRP), a ubiquitous initiator of protein translation. Eur J Biochem 228: 531–550.
  • Ma M, Geiger JD, Nath A (1994). Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes. J Virol 68: 6824–6828.
  • Maragakis NJ, Rothstein JD (2001). Glutamate transporters in neurologic disease. Arch Neurol 58: 365–370.
  • Miller MA, Cloyd MW, Liebmann J, Rinaldo CR Jr, Islam KR, Wang SZS, Mietzner TA, Montelaro RC (1993). Alter-ations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 196: 89–100.
  • Morgello S, Uson RR, Schwartz EJ, Haber RS (1995). The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia 14: 43–54.
  • Nuovo GJ, Gallery F, MacConnell P, Braun A (1994). In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acid and tumor necrosis-alpha RNA in the central nervous system. Am J Pathol 144: 659–666.
  • Nye KE, Pinching AJ (1990). HIV infection of H9 lym-phoblastoid cells chronically activates the inositol polyphosphate pathway. AIDS 4: 41–45.
  • Ohba Y, Ikuta K, Ogura A, Matsuda J, Mochizuki N, Nagashima K, Kurokawa K, Mayer BJ, Maki K, Miyazaki J, Matsuda M (2001). Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO 120: 3333–3341.
  • Oliet SHR, Piet R, Poulain DA (2001). Control of glutamate clearance and synaptic efficacy by glial coverage of neu-rons. Science 292: 923–926.
  • Patton HK, Zhou Z-H, Bubien JK, Benveniste EN, Benos DJ (2000). gp120-induced alterations of human astrocyte function: Na+/N+ exchange, K+ conductance, and glu-tamate flux. Am J Physiol Cell Physiol 279: C700–C708.
  • Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasolo H, Krohn K (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001–1008.
  • Rezaie P, Trillo-Pazos G, Everall 113, Male DK (2002). Ex-pression of /3-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: poten-tial role of chemokines in the developing CNS. Glia 37: 64–75.
  • Roy S, Katze MG, Parkin NT, Edery I, Hovanessian AG, Sonenberg N (1990). Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene prod-uct. Science 247: 1216–1219.
  • Rutka JT, Murakami M, Dirks PB, Hubbard SL, Becker LE, Fukuyama K, Jung S, Tsugu A, Matsuzawa K (1997). Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 87: 420–430.
  • Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich TA, Blumberg BM (1994). Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44: 474–481.
  • Schneider-Schaulies J, Schneider-Schaulies S, Brinkmann R, Tas P, Halbriigge M, Walter U, Holmes HC, Ter Meullen V (1992). HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology 191: 765–772.
  • Schubert D (1984). Developmental biology of cultured nerve, muscle, and glia. New York: Wiley and Sons.
  • Shahabuddin M, McKinley G, Potash MJ, Volsky DJ (1994). Modulation of cellular gene expression of HIV type 1 infection as determined by subtractive hybridization cloning: downregulation of thymosin /34 in vitro and in vivo. AIDS Res Hum Retroviruses 10: 1525–1529.
  • Shahabuddin M, Volsky B, Kim H, Sakai K, Volsky DJ (1992). Regulated expression of human immunodefi-ciency virus type 1 in human glial cells: induction of dormant virus. Path obio/ogy 60: 195–205.
  • Sharer LR (1992). Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 51: 3–11.
  • Simm M, Su Z-Z, Huang EY, Chen Y, Jiang H, Volsky DJ, Fisher PB (2001). Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid sub-traction hybridization, RaSH. Gene 269: 93–101.
  • Speth C, Stöckl G, Mohsenipour I, Wiirzner R, Stoiber H, Lass-Flörl C, Dierich MP (2001). Human immun-odeficiency virus type 1 induces expression of com-plement factors in human astrocytes. J Virol 75: 2604–2615.
  • Su Z-Z, Austin VA, Zimmer SG, Fisher PB (1993). Defin-ing the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Oncogene 8: 1211-1219.
  • Su Z-Z, Kang D-C, Chen Y, Pekarskaya O, Chao W, Volsky DJ, Fisher PB (2002). Identification and cloning of hu-man astrocyte genes displaying elevated expression af-ter infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21: 3592–3602.
  • Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M (1999). HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 9: 997–103.
  • Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol 39: 705–711.
  • Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, Matsuda M (1994). C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of Crk and GRB2/ASH proteins. Proc Natl Acad Sci USA 91: 3443–3447.
  • Tanaka S, Ouchi T, Hanafusa H (1997). Downstream of Crk adaptor signaling pathway: Activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G. Proc Natl Acad Sci USA 94: 2356–2361.
  • Testa JE, Brooks PC, Lin JM, Quigley JP (1999). Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59: 3812–3820.
  • Tornatore C, Chandra R, Berger JR, Major EO (1994). HIV-1 infection of subcortical astrocytes in the pediatric CNS. Neurology 44: 481–487.
  • Tornatore C, Nath A, Amemiya K, Major EO (1991). Per-sistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J Virol 65: 6094–6100.
  • Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001). Control of synapse number by glia. Science 291: 657–660.
  • Verkhratsky A, Orkand RK, Kettenmann H (1998). Glial cal-cium: homeostasis and signaling function. Physiol Rev 78: 100–130.
  • Westendorp MO, Li-Weber M, Frank RW, Krammer PH (1994). Human immunodeficiency virus type 1 tat up-regulates interleukin-2 secretion in activated T cells. J Virol 68: 4177–4185.
  • Wilson EM, Oh Y, Hwa V, Rosenfeld RG (2001). Interaction of IGF-binding protein-related protein 1 with a novel protein, neuroendocrine differentiation factor, results in neuroendocrine differentiation of prostate cancer cells. J Clin Endocrinol Metab 86: 4504–4511.
  • Yafiez-Mó M, Alfranca A, Cabafias C, Marazuela M, Tejedor R, Ursa MA, Ashman LK, de Lanclazuri MO, Sanchez-Madrid F (1998). Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with a3/31 integrin localized at endothe-lial lateral junctions. J Cell Biol 141: 791–804.
  • Yeung MC, Pulliam L, Lau AS (1995). The HIV enve-lope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necro-sis factor-alpha. AIDS 9: 137–143.
  • York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJS (1998). Rap1 mediates sustained MAP ki-nase activation induced by nerve growth factor. Nature 392: 622–626.
  • Zheng J, Ghoparde A, Niemann D, Cotter RL, Thylin MR, Epstein L, Swartz JM, Shepard RB, Liu X, Nukuna A, Gendelman HE (1999). Lymphotropic virions af-fect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J Virol 73: 8256–8267.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.